Treatment With Sacubitril/valsartan Vs Valsartan Reduces New Loop Diuretic Use In PARAGON-HF

被引：0
|
作者：
Chatur, Safia [1 ]
Vaduganathan, Muthiah [1 ]
Claggett, Brian [1 ]
Vardeny, Orly [2 ]
Jering, Karola [1 ]
Desai, Akshay [1 ]
Pfeffer, Marc [1 ]
McMurray, John
Solomon, Scott [1 ]
机构：
[1] Mass Gen Brigham, Boston, MA USA
[2] Univ Minnesota Med Sch, Minneapolis, MN USA
来源：
JOURNAL OF CARDIAC FAILURE | 2023年 / 29卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
287
引用
收藏
页码：670 / 670
页数：1
相关论文
共 50 条
  • [21] Unravelling the effect of sacubitril/valsartan on loop diuretic dosing
    ter Maaten, Jozine M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (03) : 342 - 344
  • [22] Effects of sacubitril/valsartan versus valsartan on renal function in patients with and without diabetes and heart failure with preserved ejection fraction: insights from PARAGON-HF
    Peikert, Alexander
    Vaduganathan, Muthiah
    Mc Causland, Finnian
    Claggett, Brian L.
    Chatur, Safia
    Packer, Milton
    Pfeffer, Marc A.
    Zannad, Faiez
    Lefkowitz, Martin P.
    Pieske, Burkert
    Duengen, Hans-Dirk
    McMurray, John J. V.
    Solomon, Scott D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (05) : 794 - 803
  • [23] PARAGON-HF - considerations for potential use of sacubitril-valsartan in real-world heart failure with mildly reduced ejection fraction
    Lund, Lars H.
    Savarese, Gianluigi
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (12) : 1012 - 1013
  • [24] Projected lifetime benefits of sacubitril/valsartan on event-free survival in patients with HFmrEF and HFpEF in the PARAGON-HF trial
    Foa, A. Alberto
    Claggett, B. L.
    Miao, M.
    Pabon, M.
    Lu, H.
    Pfeffer, M. A.
    Packer, M.
    Rouleau, J. L.
    Lefkowitz, M.
    Desai, A. S.
    Mcmurray, J. J. V.
    Solomon, S. D.
    Vaduganathan, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 225 - 226
  • [25] Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial
    Vardeny, Orly
    Claggett, Brian
    Kachadourian, Jessica
    Desai, Akshay S.
    Packer, Milton
    Rouleau, Jean
    Zile, Michael R.
    Swedberg, Karl
    Lefkowitz, Martin
    Shi, Victor
    McMurray, John J. V.
    Solomon, Scott D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (03) : 337 - 341
  • [26] Reduced Loop Diuretic Use in Patients Taking Sacubitril/Valsartan Compared With Enalapril: The Paradigm-HF Study
    Vardeny, Orly
    Claggett, Brian
    Kachadourian, Jessica
    Packer, Milton
    Zile, Michael
    Rouleau, Jean
    Swedberg, Karl
    Shi, Victor
    Lefkowitz, Martin
    McMurray, John
    Solomon, Scott D.
    CIRCULATION, 2016, 134
  • [27] Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF
    Dewan, Pooja
    Shen, Li
    Ferreira, Joao Pedro
    Jhund, Pardeep S.
    Anand, Inder S.
    Chandra, Alvin
    Chiang, Lu-May
    Claggett, Brian
    Desai, Akshay S.
    Gong, Jianjian
    Lam, Carolyn S. P.
    Lefkowitz, Martin P.
    Maggioni, Aldo P.
    Martinez, Felipe
    Packer, Milton
    Redfield, Margaret M.
    Rouleau, Jean L.
    van Veldhuisen, Dirk J.
    Zannad, Faiez
    Zile, Michael R.
    Solomon, Scott D.
    McMurray, John J. V.
    CIRCULATION, 2024, 150 (04) : 272 - 282
  • [28] Serum uric acid, influence of sacubitril/valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON-HF
    Selvaraj, S.
    Claggett, B. L.
    Veldhuisen, D. V.
    Anand, I. S.
    Pieske, B.
    Rouleau, J. L.
    Zile, M. R.
    Shi, V. C.
    Lelkowite, M. P.
    McMurray, J. J., V
    Solomon, S. D.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1066 - 1066
  • [29] Sacubitril-Valsartan for the Treatment of Heart Failure: Time for a Paragon?
    Del Buono, Marco Giuseppe
    Bonaventura, Aldo
    Vecchie, Alessandra
    Wohlford, George F.
    Dixon, Dave L.
    Van Tassel, Benjamin W.
    Abbate, Antonio
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2020, 75 (02) : 105 - 107
  • [30] Cardio-Kidney-metabolic overlap in HFpEF: cardiac structure and function, clinical outcomes, and response to sacubitril/valsartan in PARAGON-HF
    Christian, M. C. H. Mats
    Lassen, Hoejbjerg
    Ostrominski, J. W.
    Claggett, B. L.
    Packer, M.
    Zile, M.
    Desai, A. S.
    Pfeffer, M.
    Lefkowitz, M.
    Mcmurray, J. J. V.
    Solomon, S. D.
    Vaduganathan, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 345 - 345
12345